Sign in

Epidural steroid injections: efficacy and safety

Procedural · G4c · Reviewed by a board-certified pain physician on October 31, 2026

Bottom line

Epidural steroids give a small, short-term benefit for lumbosacral radicular pain. Their rare catastrophic risks are embolic, so use nonparticulate dexamethasone for transforaminal injections, and do not do high-risk levels without contrast.

Key points

  1. Expect modest, short-lived benefit. A Cochrane review of 25 placebo-controlled trials found epidural steroids probably slightly reduce leg pain and disability at short-term follow-up, by less than 10 points on a 0–100 scale 1.
  2. Particulate steroid is the embolic hazard. Catastrophic cord and brain infarctions after cervical transforaminal injection are attributed to particulate steroid entering a vertebral or radicular artery; an FDA-convened working group advised nonparticulate steroid 2.
  3. Steroid labels carry a warning. Triamcinolone labeling warns of spinal cord infarction, paraplegia, quadriplegia, cortical blindness and stroke after epidural use, with and without fluoroscopy, and states epidural use is not approved 3.
  4. Contrast unavailability changes the plan. Transforaminal injections at L2 and above, atlanto-axial and atlanto-occipital joint injections and sympathetic blocks should be postponed without contrast because of radiculomedullary artery risk 4.
  5. Below L2, only nonparticulate steroid without contrast. If a lower transforaminal injection proceeds without contrast, use only a nonparticulate steroid such as dexamethasone 4.
  6. Interlaminar without contrast: drop the local anesthetic. Consider omitting local anesthetic to avoid a high or total spinal if dura is breached; this is strongly recommended for cervical interlaminar injections 4.

Watch for

Gadolinium is not a safe substitute for iodinated contrast in epidural injections: intrathecal gadolinium is neurotoxic and can be catastrophic 4.

High-yield for the exam

  • The 2015 working group combined the FDA Safe Use Initiative, an expert panel and 13 societies, producing 17 clinical considerations 2.
  • Lumbar interlaminar injections and medial branch blocks are lowest-importance procedures that may proceed without contrast 4.
  • Without contrast, consider preservative-free dexamethasone because preservative-containing steroid given intrathecally is linked to arachnoiditis 4.
  • Do not draw contrast from the same vial for multiple patients, because of infection risk 4.
  • Minor adverse events reported after epidural steroids included post-dural puncture headache, vasovagal reactions and hypotension 1.
  • The Cochrane effects were judged too small to be clinically important for many patients and clinicians 1.
  • One trial reported a retroperitoneal hematoma in a patient on anticoagulant therapy 1.
  • Cervical transforaminal injections and stellate blocks may be done without contrast only by experts using ultrasound to see arteries 4.

Numbers to know

Item Value
Cochrane trials 25 trials, 2470 participants 1
Leg pain difference, short term −4.93 on 0–100 1
Disability difference, short term −4.18 on 0–100 1
Short-term window >2 weeks to ≤3 months 1
Highest-risk transforaminal levels cervical, thoracic, L2 and above 4
Working group considerations 17 2
Minor adverse events vs placebo RR 1.14 (very low quality) 1

Common traps

  • Choosing particulate triamcinolone for a cervical transforaminal injection 2.
  • Switching to a transforaminal approach when contrast is unavailable 4.
  • Assuming fluoroscopy alone prevents catastrophic events; label reports occurred with and without it 3.
  • Promising long-lasting relief from a single epidural steroid 1.

Practise this topic

5 more questions on this topic in the full question bank, with explanations and sources.

Sources

  1. Oliveira CB, et al. Epidural corticosteroid injections for lumbosacral radicular pain. Cochrane Database Syst Rev, 2020. pubmed.ncbi.nlm.nih.gov/32271952/
  2. Rathmell JP, et al. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology, 2015. pubmed.ncbi.nlm.nih.gov/25668411/
  3. US Food and Drug Administration. KENALOG-40 and KENALOG-80 (triamcinolone acetonide injectable suspension) prescribing information. DailyMed, 2024. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf970688-cd
  4. Schuster NM, et al. Best practices for interventional pain procedures in the setting of an iodinated contrast media shortage: a multisociety practice advisory. Interv Pain Med, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC11372943/

Related topics

Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.